找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanoparticle-Mediated Immunotherapy; Tuan Vo-Dinh Book 2021 Springer Nature Switzerland AG 2021 multifunction nanoparticles in medicine.ca

[復(fù)制鏈接]
樓主: 味覺沒有
21#
發(fā)表于 2025-3-25 04:23:23 | 只看該作者
Development of Nanoparticles as a Vaccine Platform. In recent years, due to climate and environmental changes, inoculation against various infectious diseases has become increasingly important. When purified proteins or peptides are used as an antigen for inoculation, the effectiveness of the vaccination is often insufficient. To strengthen the imm
22#
發(fā)表于 2025-3-25 08:25:09 | 只看該作者
23#
發(fā)表于 2025-3-25 14:31:24 | 只看該作者
24#
發(fā)表于 2025-3-25 19:02:12 | 只看該作者
Bioanalysishttp://image.papertrans.cn/n/image/660861.jpg
25#
發(fā)表于 2025-3-25 21:35:55 | 只看該作者
https://doi.org/10.1007/978-3-030-78338-9multifunction nanoparticles in medicine; cancer nanotechnology; nanoparticle cancer treatment; nanomedi
26#
發(fā)表于 2025-3-26 00:51:53 | 只看該作者
27#
發(fā)表于 2025-3-26 07:01:55 | 只看該作者
Nanoparticle-Mediated Immunotherapy978-3-030-78338-9Series ISSN 2364-1118 Series E-ISSN 2364-1126
28#
發(fā)表于 2025-3-26 10:02:28 | 只看該作者
2364-1118 ls, and systems design.Focuses on clinical potential and tra.This book is intended to serve as an authoritative reference source for a broad audience involved in the research, teaching, learning, and practice of nanotechnology in immunotherapy. The combination of nanotechnology and immunotherapy is
29#
發(fā)表于 2025-3-26 12:47:48 | 只看該作者
Multifunctional Gold Nanostars for Sensitive Detection, Photothermal Treatment and Immunotherapy of i-cancer immune response, “Cancer Vaccine” effect, to prevent cancer recurrence. Therefore, the biocompatible GNS nanoparticles have the promise for future clinical translation to improve brain cancer diagnostics and therapeutics.
30#
發(fā)表于 2025-3-26 17:18:44 | 只看該作者
Immunotherapy: From Discovery to Bedsides for new treatments in the immune-oncology space. Herein we review the broad categories of immunotherapy, as well as discuss the pathway(s) for bringing promising treatments to the clinic. Challenges posed by immune-oncology therapies have led to shifts in approaches to clinical trials and we will discuss these as well.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 09:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
红桥区| 灵石县| 思茅市| 鸡东县| 龙陵县| 红河县| 余庆县| 嘉定区| 土默特右旗| 含山县| 西城区| 永新县| 东山县| 曲周县| 宁陵县| 石棉县| 高清| 荣成市| 那曲县| 尉氏县| 都兰县| 辰溪县| 崇文区| 乌拉特前旗| 甘孜| 穆棱市| 乌兰县| 荔浦县| 腾冲县| 湖南省| 长顺县| 加查县| 金川县| 开远市| 瑞昌市| 榆林市| 修文县| 堆龙德庆县| 徐州市| 鸡泽县| 东阿县|